HomeDMN • FRA
add
Diamyd Medical AB
Nakaraang pagsara
€0.94
Sakop ng araw
€0.86 - €0.86
Sakop ng taon
€0.65 - €1.62
Market cap
1.32B SEK
Average na Volume
14.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Ago 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 19.00K | 5.56% |
Gastos sa pagpapatakbo | 45.81M | 0.17% |
Net na kita | -44.86M | 9.80% |
Net profit margin | -236.13K | 14.55% |
Kita sa bawat share | — | — |
EBITDA | -44.87M | 0.46% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Ago 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 277.18M | 109.41% |
Kabuuang asset | 352.64M | 62.48% |
Kabuuang sagutin | 72.64M | 2.14% |
Kabuuang equity | 280.00M | — |
Natitirang share | 137.50M | — |
Presyo para makapag-book | 0.46 | — |
Return on assets | -30.90% | — |
Return on capital | -38.46% | — |
Cash Flow
Net change in cash
| (SEK) | Ago 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -44.86M | 9.80% |
Cash mula sa mga operasyon | -35.94M | -23.25% |
Cash mula sa pag-invest | -2.37M | -112.60% |
Cash mula sa financing | -1.07M | -28.16% |
Net change in cash | -42.08M | -309.55% |
Malayang cash flow | -29.96M | -101.06% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
39
